US FDA Issues Warning Letter for Alkem Laboratories Amaliya Facility
Alkem Laboratories Ltd 路 Others (Uncategorized) 路 19 Nov 2026, 7:01 pm
US FDA Issues Warning Letter for Alkem Laboratories Amaliya Facility Alkem Laboratories received a Warning Letter dated 18th Nov'26 from the US FDA for its manufacturing facility located at Amaliya, Daman. This follows an inspection conducted between 20th Apr'26 and 1st May'26, which was previously classified as Official Action Indicated (OAI). The company stated it will respond within the stipulated timeline and continues to manufacture and supply approved products to the U.S. market. The warning letter currently presents no material impact on operations or financials.
Original exchange filing (PDF)
More announcements from Alkem Laboratories Ltd
- Please find attached herewith Q2 H1FY2027 - Earnings Conference Call Transcript 路 18 Nov 2026
- With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the audio recording of the '' Q2 and H1FY27 Earnings Conference Call'' .... 路 13 Nov 2026
- We wish to inform you that the Company has appointed Mr. Gopal Kothari as the CFO and KMP of the Company wef 2nd Dec, 2026. 路 12 Nov 2026
- Pl find enclosed press release and analyst presentation on Q2 and H1FY27 earnings and business updates of the Company 路 12 Nov 2026
- Pl find enclosed unaudited financial results along with Limited Review Report of the Company for quarter and half year ended 30th Sept, 2026. 路 12 Nov 2026
- Alkem Laboratories Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 12 Nov 2026
- Please find enclosed herewith the outcome of Board meeting dated 12th Nov, 2026. The meeting of the Board of Directors of the Company commenced at 11.30 am and concluded at 13.40. 路 12 Nov 2026
- Please find attached herewith intimation of incorporation of subsidiary in the form of Joint Venture. 路 09 Nov 2026
